Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
暂无分享,去创建一个
Susan Cooley | G. Hogarty | R. Ulrich | Gerard E Hogarty | Samuel Flesher | Richard Ulrich | Mary Carter | Deborah Greenwald | Michael Pogue-Geile | Matcheri Kechavan | Ann Louise DiBarry | Ann Garrett | Haranath Parepally | Rebecca Zoretich | M. Pogue-Geile | H. Parepally | R. Zoretich | D. Greenwald | M. Carter | S. Flesher | A. L. DiBarry | S. Cooley | Matcheri Kechavan | A. Garrett | Rebecca Zoretich
[1] P. Corrigan,et al. Schizophrenic patients' sensitivity to social cues: the role of abstraction. , 1993, The American journal of psychiatry.
[2] G. Hogarty,et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. , 1997, The American journal of psychiatry.
[3] J. Cadet,et al. Social Intelligence, a Neurological System? , 1989, Psychological reports.
[4] Michael F. Green,et al. What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.
[5] H. Kraemer,et al. Mediators and moderators of treatment effects in randomized clinical trials. , 2002, Archives of general psychiatry.
[6] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[7] W. Tryon,et al. Effectiveness of attention training in schizophrenia. , 1998, Schizophrenia bulletin.
[8] J. Lieberman,et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.
[9] Alan D. Lopez,et al. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.
[10] H. Kraemer. To increase power in randomized clinical trials without increasing sample size. , 1991, Psychopharmacology bulletin.
[11] Philip D. Harvey,et al. Treatment of cognitive deficits in schizophrenia. , 2006, Current opinion in investigational drugs.
[12] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients. , 1974, Archives of general psychiatry.
[13] J. Fleiss,et al. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.
[14] Jane S. Paulsen,et al. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.
[15] B. Everitt,et al. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. , 1999, Schizophrenia bulletin.
[16] G. Hogarty,et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. , 1997, The American journal of psychiatry.
[17] N C Andreasen,et al. Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms , 1995 .
[18] J. McEvoy,et al. Pharmacotherapy of impaired affect in recovering schizophrenic patients. , 1995, Archives of general psychiatry.
[19] S. Silverstein,et al. Shaping attention span: an operant conditioning procedure to improve neurocognition and functioning in schizophrenia. , 2001, Schizophrenia bulletin.
[20] S. Silverstein. Information processing, social cognition, and psychiatric rehabilitation in schizophrenia. , 1997, Psychiatry.
[21] T. K. Srull,et al. Handbook of Social Cognition , 1993 .
[22] G. Hogarty,et al. Practice principles of cognitive enhancement therapy for schizophrenia. , 1999, Schizophrenia bulletin.
[23] P. Williamson,et al. Neuropsychological correlates of syndromes in schizophrenia , 1997, British Journal of Psychiatry.
[24] W. Carpenter,et al. Domains of Psychopathology: An Approach to the Reduction of Heterogeneity in Schizophrenia , 1994, The Journal of nervous and mental disease.
[25] P. Liddle. Schizophrenic syndromes, cognitive performance and neurological dysfunction , 1987, Psychological Medicine.
[26] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. , 1973, Archives of general psychiatry.
[27] W. Spaulding,et al. Effects of cognitive treatment in psychiatric rehabilitation. , 1999, Schizophrenia bulletin.
[28] V. Reyna,et al. Gist is the grist: Fuzzy-trace theory and the new intuitionism☆ , 1990 .
[29] J. Barth,et al. The Halstead-Reitan Neuropsychological Test Battery. , 2000 .
[30] Michael F. Green,et al. Normal neurocognitive performance after extended practice in patients with schizophrenia , 1997, Schizophrenia Research.
[31] M. Keshavan,et al. Brain maturational processes and delayed onset in schizophrenia , 1999, Development and Psychopathology.
[32] Robert K. Heaton,et al. Wisconsin Card Sorting Test Manual – Revised and Expanded , 1993 .
[33] W. Spaulding,et al. Applications of experimental psychopathology in psychiatric rehabilitation. , 1986, Schizophrenia bulletin.
[34] D. Velligan,et al. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. , 2000, The American journal of psychiatry.
[35] B. Wexler,et al. Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. , 2001, Archives of general psychiatry.
[36] C. Correll,et al. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. , 2003, The American journal of psychiatry.
[37] L. Mussgay,et al. Reduction of schizophrenic deficits by cognitive training: An evaluative study , 2005, European archives of psychiatry and neurological sciences.
[38] O. G. Jr. Brim,et al. Socialization Through the Life Cycle , 1968 .
[39] J. Lieberman,et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. , 1997, Archives of general psychiatry.
[40] N. Revheim,et al. The remediation of problem-solving skills in schizophrenia. , 2001, Schizophrenia bulletin.
[41] P. Berger,et al. Social Construction of Reality , 1991, The SAGE International Encyclopedia of Mass Media and Society.
[42] D. A. Johnson,et al. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences , 1983, Acta psychiatrica Scandinavica.
[43] E. Walker,et al. Intelligence in schizophrenia: meta-analysis of the research. , 1984, Schizophrenia bulletin.
[44] M.P.A. Judith Jaeger Ph.D.,et al. NEUROPSYCHIATRIC REHABILITATION FOR PERSISTENT MENTAL ILLNESS , 2004 .
[45] J. Neale,et al. The neuropsychological signature of schizophrenia: generalized or differential deficit? , 1994, The American journal of psychiatry.
[46] J. Gold,et al. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. , 1999, Schizophrenia bulletin.
[47] G. Dunn,et al. Cognitive deficit and the prediction of rehabilitation success in a chronic psychiatric group , 1992, Psychological Medicine.
[48] T. White,et al. Syndromes of Chronic Schizophrenia and Some Clinical Correlates , 1992, British Journal of Psychiatry.
[49] R. Oades,et al. Schizophrenia: Empirical Research and Findings , 1992 .
[50] G. Hogarty,et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion. , 1986, Archives of general psychiatry.
[51] R. Liberman,et al. A controlled trial of cognitive remediation in schizophrenia. , 2002, Schizophrenia bulletin.
[52] D. Greenberg. Symptoms of Schizophrenia , 1994 .
[53] L. Diller,et al. Outcome of different treatment mixes in a multidimensional neuropsychological rehabilitation program. , 1992 .
[54] D. Levy. Psychopathology: Location, location, location: The pathway from behavior to brain locus in schizophrenia , 1996 .
[55] K. Nuechterlein,et al. Should schizophrenia be treated as a neurocognitive disorder? , 1999, European Neuropsychopharmacology.
[56] J. Lieberman,et al. Implications for the neural basis of social cognition for the study of schizophrenia. , 2003, The American journal of psychiatry.
[57] M. Green,et al. A training procedure for remediating WCST deficits in chronic psychotic patients: an adaptation of errorless learning principles. , 1996, Journal of psychiatric research.
[58] Y. Ben-Yishay,et al. Neuropsychologic Rehabilitation: Quest for a Holistic Approach , 1985 .
[59] J. Wing. A simple and reliable subclassification of chronic schizophrenia. , 1961, The Journal of mental science.
[60] A. Raskin,et al. REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF‐REPORT RATINGS OF HOSPITALIZED DEPRESSIVES , 1969, The Journal of nervous and mental disease.
[61] C. Cohen. Overcoming social amnesia: the role for a social perspective in psychiatric research and practice. , 2000, Psychiatric services.
[62] J. McEvoy,et al. Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study. , 1988, Archives of general psychiatry.
[63] R. Reitan,et al. 3/The Halstead-Reitan Neuropsychological Test Battery and Aging , 1986 .
[64] McEvoy Jp. Expert Consensus Guideline Series Treatment of Schizophrenia 1999 , 1999 .
[65] T. Wykes,et al. The Prediction of Rehabilitative Success after Three Years the use of Social, Symptom and Cognitive Variables , 1990, British Journal of Psychiatry.
[66] B. Rund,et al. A review of longitudinal studies of cognitive functions in schizophrenia patients. , 1998, Schizophrenia bulletin.
[67] K H Nuechterlein,et al. Effects of attention training on information processing in schizophrenia. , 1994, Schizophrenia bulletin.
[68] G. Hogarty,et al. Developmental theory for a cognitive enhancement therapy of schizophrenia. , 1999, Schizophrenia bulletin.
[69] H E ROSVOLD,et al. A continuous performance test of brain damage. , 1956, Journal of consulting psychology.
[70] G. Hogarty. Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment , 2002 .
[71] G. Hogarty,et al. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.
[72] P. Knapp,et al. Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. , 1984, Schizophrenia bulletin.
[73] G. Hogarty,et al. Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. , 1977, Archives of general psychiatry.
[74] S. Lawrie,et al. Errorless learning and the cognitive rehabilitation of memory-impaired schizophrenic patients , 1999, Psychological Medicine.
[75] D. Jeste,et al. Stability and course of neuropsychological deficits in schizophrenia. , 2001, Archives of general psychiatry.
[76] R. Heaton,et al. Neuropsychological test results associated with psychiatric disorders in adults. , 1978, Psychological bulletin.
[77] J. T. Marsh,et al. Information-processing deficits across childhood- and adult-onset schizophrenia. , 1994, Schizophrenia bulletin.
[78] M. Hannan,et al. Estimation in Panel Models: Results in Pooling Cross-Sections and Time Series , 1977 .
[79] P F Liddle,et al. Schizophrenic Syndromes and Frontal Lobe Performance , 1991, British Journal of Psychiatry.
[80] D. Braff,et al. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.
[81] W. Spaulding,et al. Cognitive functioning in schizophrenia: implications for psychiatric rehabilitation. , 1999, Schizophrenia bulletin.